Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.9200
0.00 (0.00%)
Aug 26, 2026, 5:35 PM CET
ETR:MAK Market Cap
ETR:MAK has a market cap or net worth of €19.29 million as of August 26, 2026. Its market cap has decreased by -28.13% in one year.
Market Cap
19.29M
Enterprise Value
132.53M
Revenue
118.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.92
ChartMarket Cap Chart
Since February 17, 1998, ETR:MAK's market cap has decreased from 110.87M to 19.29M, a decrease of -82.60%. That is a compound annual growth rate of -5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 19.29M | -9.80% |
| Dec 30, 2025 | 21.39M | -25.00% |
| Dec 30, 2024 | 28.52M | -52.45% |
| Dec 29, 2023 | 59.97M | 71.26% |
| Dec 29, 2022 | 35.02M | -65.64% |
| Dec 30, 2021 | 101.91M | 10.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.98B |
| Bayer Aktiengesellschaft | 47.20B |
| Siemens Healthineers AG | 44.75B |
| Fresenius SE & Co. KGaA | 26.25B |
| FamiCord AG | 49.68M |
| Pentixapharm Holding AG | 47.21M |
| MeVis Medical Solutions AG | 43.32M |
| NanoRepro AG | 24.09M |